SII, PATH meningococcal meningitis conjugate vaccine receive

SII: WHO prequalification—which ensures a vaccine meets strict international quality, safety, and efficacy standards—was supported by extensive clinical studies in The Gambia, India, and Mali that demonstrated a high level of safety and immunogenicity. Importantly, prequalification allows MenFive to be procured by United Nations agencies and Gavi, The Vaccine Alliance.

Related Keywords

India , Pune , Maharashtra , Gambia , United Kingdom , Senegal , Mali , Ethiopia , Nanthalile Mugala , Andrew Mitchell , Adar Poonawalla , Vaccine Alliance , National Institute Of Allergy , International Development , Infectious Diseases Clinical Research Consortium , United Nations , Serum Institute Of India , Serum Institute Of India Pvt Ltd , Development Office , National Institutes Of Health , World Health Organisation , Serum Institute , India Pvt Ltd , Executive Director , International Development Minister , Defeat Meningitis , Africa Region , National Institute , Infectious Diseases , National Institutes , Sii , Path , Conjugate Vaccine , Meningococcal Meningitis , Ho Prequalification , Drug Development , Health News , Penfive ,